# Autosomal Dominant Calpainopathy in a Diabetic Patient Complicated by Functional Gitelman Syndrome

**Authors:** Kabilash Manivalli Peterpalaniswami, Krishnaswamy Madhavan, Gerry George Mathew, V. Jayaprakash

PMC · DOI: 10.1155/carm/4210190 · Case Reports in Medicine · 2025-06-05

## TL;DR

A diabetic patient with muscle weakness was found to have a rare condition combining Gitelman syndrome and calpainopathy, showing how these two disorders can coexist and affect the body.

## Contribution

This case report presents a rare combination of autosomal dominant calpainopathy and Gitelman syndrome in a diabetic patient.

## Key findings

- The patient exhibited hypokalemia, hypomagnesemia, and metabolic alkalosis consistent with Gitelman syndrome.
- Genetic analysis identified a heterozygous mutation in CAPN3, indicating autosomal dominant calpainopathy.
- Treatment with potassium and magnesium supplements improved muscle strength and resolved electrolyte abnormalities.

## Abstract

Adult-onset Gitelman syndrome with calpainopathy is a rare clinical condition in patients with diabetes mellitus. We present the case of a 52-year-old male diabetic patient who presented with muscle weakness and fatigue. On evaluation, he had reduced power in the thigh and pelvic girdle muscles. Laboratory tests revealed hypokalemia, hypomagnesemia, metabolic alkalosis, kaliuresis, and hypocalciuria, which led to the diagnosis of Gitelman syndrome. Electromyography revealed a myopathic pattern with polyphasic motor unit action potentials of a short duration. Genetic analysis revealed a heterozygous mutation in CAPN3, suggestive of autosomal dominant calpainopathy or limb girdle muscular dystrophy. He was administered intravenous potassium and magnesium supplements, followed by oral potassium chloride, magnesium oxide, and potassium-sparing diuretics. The patient had improved muscle strength on follow-up, with resolution of the electrolyte abnormalities. This case report highlights this rare clinical entity, its variable clinical manifestations, and the pathophysiological mechanisms involved in electrolyte abnormalities.

## Linked entities

- **Genes:** CAPN3 (calpain 3) [NCBI Gene 825]
- **Chemicals:** potassium (PubChem CID 813), magnesium (PubChem CID 5462224), potassium chloride (PubChem CID 4873), magnesium oxide (PubChem CID 14792)
- **Diseases:** diabetes mellitus (MONDO:0005015), Gitelman syndrome (MONDO:0009904), calpainopathy (MONDO:0009675), limb girdle muscular dystrophy (MONDO:0016971)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12163201/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12163201/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12163201/full.md

---
Source: https://tomesphere.com/paper/PMC12163201